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Abstract
Insect proteases are implicated in Bacillus thuringiensis insecticidal proteins mode of action determining toxin specificity and sensitivity. Few
data are available on the involvement of proteases in the later steps of toxicity such as protease interaction with toxin–receptor complexes and the
pore formation process. In this study, a Colorado potato beetle (CPB) midgut membrane metalloprotease was found to be involved in the
proteolytic processing of Cry3Aa. Interaction of Cry3Aa with BBMV membrane proteases resulted in a distinct pattern of proteolysis. Cleavage
was demonstrated to occur in protease accessible regions of domain III and was specifically inhibited by the metalloprotease inhibitors 1,10-
phenanthroline and acetohydroxamic acid. Proteolytic inhibition by a peptide representing a segment of proteolysis in domain III and the
metalloprotease inhibitor acetohydroxamic acid correlated with increased pore formation, evidencing that Cry3Aa is a specific target of a CPB
membrane metalloprotease that degrades potentially active toxin.
© 2007 Elsevier B.V. All rights reserved.Keywords: Bacillus thuringiensis; Colorado potato beetle; Insecticidal toxin; Protease; Cry3Aa proteolysis; Pore formation1. Introduction
Bacillus thuringiensis (Bt) insecticidal proteins mode of
action has been described as a step-wise mechanism that initiates
with ingestion, followed by solubilization and protease activa-
tion in the lumen of the insect midgut, and culminates in the
vicinity of the midgut membrane with the postactivation events
of toxin–receptor interaction, oligomerization and pore forma-
tion. To exert their action, toxins need to be previously activated
by insect midgut proteases that must play a major role in toxicity
[1].
Lepidopteran-active toxins are obtained via proteolytic
processing which has been reported to proceed by removal of
both N- and C-terminal peptides. The 73 kDa coleopteran-
specific Cry3Aa toxin has been considered as a naturally
truncated version of the lepidopteran toxins [2]. Nevertheless,
extensive N-terminal processing of this toxin resulted in a⁎ Corresponding author. Fax: +34 96 354 30 29.
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doi:10.1016/j.bbamem.2007.06.014more toxic form than the native toxin [3]. In Leptinotarsa
decemlineata, Colorado potato beetle (CPB), although midgut
proteases are mainly cysteine and aspartate proteinases [4] a
chymotrypsin-like serine-protease has been proposed to
activate Cry3Aa toxin to a 49-kDa form which can be
detected in vivo [5] and is able to bind to CPB brush border
membrane vesicles (BBMV) [6].
The activity or composition of gut proteases influences
susceptibility by insects to Cry toxins and may provide the basis
for the specificity of Bt in different insect species and resistance
development [7]. In CPB, Loseva et al. [8] reported that
resistance to Cry3Aa toxin correlates with the presence of
different forms of digestive proteases in a resistant strain that
also displayed decreased binding of the toxin.
Excessive toxin degradation has been implicated in insen-
sivity to Bt toxins. Strong proteolytic activity of the midgut
juice contributed to further degradation of activated toxin in
Heliothis armigera [9] and in Choristoneura fumiferana [10]
rendering both insects less susceptible to Bt toxins than Bombyx
mori where activated toxin remains unprocessed. Resistance to
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has been related to slower Cry1Ac protoxin activation and
faster processing of the active toxin than in the susceptible
strain [11].
While there is reasonable understanding of the effect of
soluble midgut digestive proteases in toxin activation, little is
known about the role of membrane protease processing of Bt
toxins in relation to toxin–receptor complex and pore
formation events of the Bt mode of action. It has been reported
that the dipteran active Cry11Aa toxin undergoes a specific
pattern of proteolysis when incubated with Culex quinquefas-
ciatus BBMV [12] and that proteases associated with CPB
BBMV, but not gut juice, cleave the Cry3Aa toxin generating a
38-kDa fragment [8]. In both cases the functional significance
of this processing remains unclear. We have previously
demonstrated that Cry3Aa toxin pre-incubated with CPB
BBMV in the absence of midgut juice proteases form pores
more efficiently that the native toxin [13], suggesting that
membrane molecules could be involved in the mechanism of
activation of this toxin for effective membrane insertion, as it
had been proposed for the lepidopteran-specific toxin Cry1Ab
[14]. In contrast, Kirouac et al. [15] recently reported that
Cry1Aa toxin, once activated by midgut juice proteases, is
completely functional and does not require further BBMV
proteolysis.
In the present study, we show that Cry3Aa toxin is
specifically cleaved by BBMV associated metalloproteases,
which drastically reduce the pore forming activity of this
protein. Elimination of Bt toxins via degradation by midgut
membrane proteases may account for the observed decrease in
pore formation and has to be considered as an additional
mechanism that impairs the Cry toxins entomopathogenic
action. Membrane associated proteases could therefore be
involved either in toxin activation or in its further degradation,
both at the same time or neither.2. Materials and methods
2.1. Insects
A laboratory colony of L. decemlineata (Colorado potato beetle) founded
from eggs taken from the field was used. Larvae and adults were reared on
potato leaves at 25 °C and with a photoperiod of 16:8 (light/dark).
2.2. Preparation of brush border membrane vesicles (BBMV)
BBMV were prepared from last instar L. decemlineata larvae according to
the method of Wolfersberger et al. [16], as modified by Reuveni and Dunn [17].
Larvae were dissected in storage buffer (300 mM mannitol, 20 mM 2-
mercaptoethanol, 5 mM EGTA, 1 mM EDTA, 10 mM HEPES, 2.4 μg/ml
neomycin sulphate, pH 7.5) and the insect midguts obtained were immediately
frozen and stored at −80 °C until use. Frozen midguts were mechanically
homogenized in homogenization buffer (200 mM mannitol, 10 mM ascorbic
acid, 5 mMEDTA, 2 mMDTT, 10 mMHEPES, pH 7.4) for 10 s. One volume of
24 mM MgCl2 was added and the mixture incubated for 10 min. Following
centrifugation of the mixture (10 min, 6000×g at 4 °C), the supernatant was
further centrifuged (30 min, 30,000×g at 4 °C) and the final pellet suspended in
200 mMmannitol, 1 mMDTT, 1 mMHEPES–Tris, pH 7.4, frozen and stored at
−80 °C until use. The protein concentration of BBMV was measured by
Bradford's procedure [18] using bovine serum albumin (BSA) as a standard.2.3. Crystal purification
Cry3Aa crystals were produced in Bt strain BTS1. Crystal inclusions were
separated from spores and cell debris by centrifugation in discontinuous 67%,
72%, 79%, and 84% (w/v) sucrose gradients in 50 mM Tris–HCl, pH 7.5, as
described by Thomas and Ellar [19]. Crystal proteins were solubilized in 50 mM
Na2CO3, pH 10.5, at 37 °C for 12 h. Purity of the crystal preparation was
monitored by phase contrast microscopy and analyzed by 10% SDS-PAGE.
Protein concentration was measured by the protein-dye method of Bradford
[18], using BSA as a standard.
2.4. Incubation of Cry3Aa with CPB BBMV
Cry3Aa toxin (2 μM) was incubated with 20 μg BBMV in a final volume of
30 μl PBS (8 mMNa2HPO4, 2 mMKH2PO4, 150 mMNaCl, pH 7.4), for 10 min
at room temperature, and centrifuged 20 min at 12,000×g. The pellet and/or
supernatant were loaded in 10% SDS-PAGE gels and the resolved proteins were
transferred onto a nitrocellulose membrane (Millipore) and immunoblotted
against anti-Cry3Aa polyclonal antibody. The secondary antibody was alkaline
phosphatase-conjugated anti-rabbit antibody (Sigma). The immunoreactive
proteins were visualized using the ECL detection system Immobilon Western
(Millipore).
In Cry3Aa cleavage inhibition assays, incubation was performed in the
presence or absence of protease inhibitors and peptides designed to inhibit
proteolysis. The concentration and type of inhibitor used in each experiment is
described in the figure legends.
2.5. Calcein release experiments
Calcein containing CPB BBMVwere prepared as described previously [13].
Calcein leakage experiments were performed with 75 μg of calcein loaded
BBMVadded to 900 μl of 150 mMKCl, CHES 10 mM, pH 9.0, and 20 μl of the
supernatant of Cry3Aa pre-incubated with BBMV, in the presence or absence of
150 μM pep-99 peptide or 2 μM of the proteolytic cleavage inhibitor aceto-
hydroxamic acid (final concentration). Maximal leakage at the end of each
experiment was assessed by lysis with Triton X-100 (0.1% final concentration).
The increase in fluorescence due to the release of calcein in the solution was
monitored at room temperature with constant agitation in a VARIAN Cary
Eclipse Fluorescence Spectrophotometer equipped with a thermostatically
controlled cell holder, with excitation and emission wavelengths of 490 and
520 nm, respectively.
2.6. Cry3Aa labelling
Solubilized Cry3Aa toxin (200 μg) was precipitated using the Plus One
2-D Clean-Up Kit (Amersham) and re-suspended in 50 μl of buffer containing
30 mM Tris–HCl, pH 8.5, 7 M urea, 2 M thiourea and 4% (w/v) Chaps. The
protein concentration was determined by the RC-DC Protein Assay (Bio-Rad).
Minimal labelling of Cry3Aa with Cy DIGE fluorophores was performed
using succinimidyl ester of propyl-Cy3 and methyl-Cy5 fluorophores fol-
lowing Amersham Biosciences instructions.
2.7. Two-dimensional electrophoresis
The first dimension, isoelectric focusing (IEF), was performed in 3 mm×
24 cm immobiline™ Dry Strips (Amersham Biosciences) with a NL pH 3–10
gradient. The strips were rehydrated with a solution containing 7 M urea, 2 M
thiourea, 2% CHAPS, 20 mM DTT, 1.2% (v:v) Destreak (Amersham) and 0.5%
Pharmalyte 3–10 NL. Following overnight rehydration, Cy3- and Cy5-labelled
protein samples (100 μg) were loaded onto the strips using a cup loading
technique. IEF was performed in a voltage step-gradient (300 V for 3 h; 1000 V
for 6 h; 8000 V for 3 h; 8000 V 4 h; 500 V 10 h), using Ettam IPGPhor
isoelectric focusing system (Amersham Biosciences). Prior to the second
dimension (SDS-PAGE), the strips were equilibrated for 15 min in a solution
containing 50 mM Tris–HCl buffer, pH 8.6, 6 M urea, 30% glycerol, 2% SDS
1%DTT followed by a 15-min incubation with 50 mM Tris–HCl buffer, pH 8.6,
6 M urea, 30% glycerol, 2% SDS and 2.5% iodoacetamide. After equilibration,
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fluorescence glass plates. Electrophoresis was performed at 20 °C in an Ettan
DALTsix electrophoresis unit and the gels were run overnight at constant current
at 1 W per gel. Cy3- and Cy5-labelled polypeptides were detected in gels using a
Typhoon 9400TM scanner (Amersham Biosciences).
For N-terminal sequencing, after 2-D electrophoresis the gel was
electroblotted onto a PVDF membrane and protein spots excised for Edman
degradation.
3. Results
3.1. Intramolecular proteolytic cleavage of Cry3Aa catalyzed
by CPB BBMV
In a previous work we demonstrated that Cry3Aa incubation
with CPB BBMV resulted in the formation of a high molecular
weight oligomeric structure [13]. Concomitantly, we observed
that the toxin was readily proteolyzed by proteases associated to
BBMV yielding fragments which can be separated from the
membranes by centrifugation (Fig. 1, panel A). Cry3Aa was
mainly processed into three bands, with an apparent molecular
mass of 42, 30 and 26 kDa on SDS-PAGE (Fig. 1, panel A lane
2). In some supernatants where the lower molecular mass
fragments of 30 and 26 kDa appear very faint relatively to the
42-kDa fragment, a 38-kDa fragment was also observed (Fig. 4,
Panel A, first lane). No changes in the proteolytic profile were
observed increasing the incubation time up to 2 h within the pH
range from 7.4 to 11.0 (data not shown).
To analyze the polypeptide profile of Cry3Aa cleaved by
BBMV proteases, the toxin was fluorescent-labelled and the
proteolysis fragments separated by two-dimensional electro-
phoresis. Cy5-Cry3Aa labelled toxin was incubated with CPB
BBMVand the resulting soluble fraction containing the cleavage
fragments was mixed with Cy3-Cry3Aa labelled non-cleavedFig. 1. Polypeptide profile of Cry3Aa cleaved by CPB BBMV proteases. Panel A, wes
lanes 2 and 3, supernatant and pellet of Cry3Aa incubated with CPB BBMV. Pane
fragments in a mixture of 50 μg of Cy3-Cry3Aa labelled non-cleaved control toxin (
incubation with CPB BBMV (red spots). Yellow spots correspond to the superimp
indicated at the top. Note. The white space between lanes 1 and 2 denotes that the lcontrol toxin. Proteins in the mixture were separated by two-
dimensional electrophoresis (Fig. 1, panel B). Green fluorescent
spots corresponded to Cy3-Cry3Aa non-cleaved control toxin,
red spots to fragments generated by BBMV proteolytic cleavage
of Cy5-Cry3Aa toxin and yellow spots to Cry3Aa fragments that
were present in both Cy3-Cry3Aa non-cleaved toxin and
proteolyzed Cy5-Cry3Aa toxin. To characterize the proteolytic
fragments, red spots were selected and N-terminal sequenced.
Two sequences were unambiguously determined, SLDGA and
DKV, with serine-578 and aspartic acid-631 of the deduced
Cry3Aa amino acid sequence at the N-terminus, respectively,
both located in domain III loops facing the same surface of
interaction with the membrane protease (Fig. 2). The SLDGA
sequence and its flanking regions in the Cry3Aa sequence were
selected to design a 12-mer peptide, pep-99 (Ac-FTLSLDGAP-
FNQ-NH2), to be used as competitor in Cry3Aa cleavage assays
with CPB BBMV. As it is shown in Fig. 3, pep-99 prevented
Cry3Aa proteolysis in a dose-dependent manner. This result
indicates that this sequence might be a specific target of a CPB
BBMV protease.
3.2. Inhibitors of metalloproteases prevent Cry3Aa cleavage by
CPB BBMV
To characterize the membrane proteases involved in Cry3Aa
proteolytic cleavage, the effect of a variety of protease inhibitors
was analyzed (Fig. 4, panel A). Themost effective inhibition was
observed with metalloprotease inhibitors, whereas other types
had minimal or no inhibitory effect. This suggests that a metal-
loprotease associated to CPB BBMV is responsible of Cry3Aa
cleavage. The sensitivity of Cry3Aa proteolysis to metallopro-
tease inhibitors was mainly due to 1,10-phenanthroline (Fig. 4,
panel B) which was shown to be dose-dependent (Fig. 4, paneltern blot of Cry3Aa toxin incubated with CPB BBMV. Lane 1, Cry3Aa protoxin;
l B, fluorescent scanning of the two-dimensional electrophoretic separation of
green spots) and 50 μg of Cy5-Cry3Aa labelled toxin proteolytically cleaved by
osed image of a green and a red spot. The pH range of isoelectric focusing is
anes were not contiguous in the gel.
Fig. 3. Effect on Cry3Aa proteolysis by CPB BBMV of synthetic peptide
pep-99. Western blot of the supernatants obtained after incubation of Cry3Aa
toxin with CPB BBMV in the absence or presence of increasing concentrations
of pep-99 (Ac-FTLSLDGAPFNQ-NH2).
Fig. 2. Schematic ribbon presentation of the Cry3Aa toxin three domain
organization. Molecular graphical model of Cry3Aa toxin was produced with
Chimera [30]. Highlighted in green are the segments corresponding to N-
terminal sequences of two cleavage fragments in domain III obtained by CPB
BBMV proteolysis.
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also significantly inhibited Cry3Aa proteolysis (Fig. 4, panel B).
3.3. Functional significance of BBMV proteolysis of Cry3Aa
Previous work on CPB demonstrated that Cry3Aa protein
incubated with CPB BBMV had higher pore formation activity
than the protoxin itself [13]. Therefore to assess the effect of
Cry3Aa proteolysis on the ability of this toxin to form pores in
vitro, calcein leakage experiments were carried out using the
soluble fraction of Cry3Aa pre-incubated with CPB BBMV,
where proteolytic fragments are mainly recovered. Supernatants
obtained after the pre-incubation in the presence or absence of
inhibitors of the metalloprotease inhibitors 1,10-phenanthroline
and acetohydroxamic acid, or the competitor peptide pep-99
were added to calcein loaded BBMV and the release of calcein
was monitored (Fig. 5). Unfortunately, 1,10-phenanthroline
could not be used in calcein release experiments because it
interfered with calcein fluorescence emission. Cry3Aa pore
formation activity in the presence of the metalloprotease
inhibitor acetohydroxamic acid or the competitor peptide pep-
99 was significantly higher than that of Cry3Aa. These data are
in accordance with the existence of a degradative membrane
associated proteolytic activity that if inhibited results in a higher
effective Cry3Aa concentration that efficiently forms membrane
pores.
Comparison of curves labelled 3A and 3A (BBMV pre-
incubated) in Fig. 5 also shows that interaction with BBMV is
essential to activate the toxin and, as previously reported [13],
this can be achieved only if toxin is BBMV pre-incubated. The
sequence of changes associated to the pre-incubation is not
well understood. We varied BBMV and toxin concentration,
incubation time and buffer composition and pH (data notshown), and we observed that in the experimental conditions
stated in Materials and methods the ratio toxin:BBMV in a
fixed volume is essential to effectively activate the toxin.
4. Discussion
Colorado potato beetle has become themost significant pest on
potato and other Solanacea, which includes economically
important crop plants such as tomato and eggplant. Bt based
bioinsecticides, safe for users and the environment, represent a
viable alternative for the biological control of this pest, which to
date has developed resistance to multiple synthetic chemical
insecticides. Managing the pest successfully requires identifica-
tion of midgut protease activities involved in toxin activation and/
or degradation and membrane molecules that can act as receptors
that promote membrane insertion leading to cell toxicity.
We observed that it was not possible to incubate Cry3Aa with
CPB BBMV without proteolytic cleavage, as it has been also
described for the dipteran specific Cry11Aa toxin [12]. This may
be a relevant process in the insecticidal action that diminishes
toxin effectiveness. Our observation agrees with the Cry3Aa
proteolytic processing by CPBBBMVpreviously reported [8] in
which a major 38-kDa band resistant to any further degradation
was obtained, although we also detected a 42-kDa band and in
some experiments, proteolytic fragments lower than 38 kDa.
Replicated experiments evidenced that the relative intensity of
the Cry3Aa proteolytic bands depended on the BBMV and
Cry3Aa toxin preparations, and that the proteolytic profile
obtained did not change upon prolongedBBMVincubation (data
not shown), except for the 38-kDa band that seems to be only
detected when is not completely further processed to the 30- and
26-kDa bands. Proteolysis bands resolved in two-dimensional
electrophoresis revealed a reproducible more complex mem-
brane proteolytic pattern (Fig. 1, panel B). The specific
proteolytic profile obtained upon incubation with CPB
BBMV allowed us to identify by N-terminal analysis two
cleavage sequences, SLDGA and DKV. These protease-
sensitive sequences are located in regions accessible to
proteases in Cry3Aa domain III (Fig. 2) [20]. The N-terminal
DKV polypeptide contains a block of 10 amino acids
(DKVYIDKYEFIPVN) at the extreme C-terminal of Cry3Aa
found to be almost identical in other Cry toxins, including
Fig. 4. Effect of different protease inhibitors on Cry3Aa proteolytic cleavage catalyzed by CPB BBMV. All panels show western blots of the supernatants obtained after
incubation of Cry3Aa with CPB BBMV in the absence or presence of protease inhibitors. Panel A, four different cocktails of class-specific protease inhibitors: C,
Cysteinprotease inhibitors (1 mM PMSF, 10 μM E-64, 100 μM leupeptin); M, Metalloprotease inhibitors (0.1 mM amastatin, 10 mM EDTA, 10 mM 1–10,
phenanthroline); S, Serinprotease inhibitors (1 mM PMSF, 100 μM leupeptin, 0.1 mM TPCK, 0.1 mM TLCK, 5 mM Pefabloc, 0.1 mg/ml soybean trypsin inhibitor); A,
Aspartylprotease inhibitor (50 μM pepstatin A). Panel B, four different metalloprotease inhibitors, (0.1 mM amastatin, 10 mM EDTA, 10 mM 1–10, phenanthroline,
50 mM acetohydroxamic acid); and Panel C, increasing concentrations of the metalloprotease inhibitor 1,10-phenanthroline. Lines at the left of each blot represent
molecular weight markers corresponding to 75, 50, 37 and 25 kDa.Note. Last lane, Panel B (Aha) is separated from the rest because is not adjacent to the others in the gel.
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[3,21]. This region that is essential for toxicity in Manduca
sexta [22], may also be in CPB, therefore the C-terminal
processing observed in Cry3Aa would result in a loss of
activity in vivo against CPB.
The N-terminal SLDGA polypeptide is located in a segment
on and adjacent to β-18 within domain III outer sheet of
Cry3Aa. In this region, Cry1Ac displays a six-residue insertion
unique to this toxin [23] which is important to GalNAc-
mediated receptor binding [24]. To investigate the specificity of
this site of cleavage, we designed a 12-mer peptide with an
amino acid sequence containing the SLDGA region (pep-99)
that was confirmed to effectively inhibit proteolysis (Fig. 3).
Given the multiple steps in the mechanism of action of these
pore-forming toxins, membrane permeabilization experimentsFig. 5. Analysis of Cry3Aa toxin induced calcein leakage from CPB BBMV in the ab
Experiments were performed at least in triplicate as described in Materials and
acetohydroxamic acid (2 μM), and Cry3Aa (44 nM) not pre-incubated with BBMVwe
was monitored for 1500 s, excitation and emission wavelengths of 490 and 520 nm
X-100 corresponded to 100% of released calcein.constitute a very useful approach to assess toxicity. The rate of
BBMV calcein release in the presence of this peptide was
increased, showing that Cry3Aa membrane associated proteo-
lysis leads to reduced pore formation. These results indicate that
Cry3Aa domain III is specifically recognized and cleaved by
membrane proteases, which eliminate potentially active toxin
via degradation. In H. armigera, it has been suggested that
further degradation of activated toxin may occur in vivo,
because bioassays in which HD-1 protoxin was combined with
serine protease inhibitors showed an increase of mortality from
17% to 70% [9].
To analyze the effect of Cry3Aa proteolysis on the in vitro
pore formation activity of this toxin, protease inhibitors that
effectively blocked toxin proteolytic processing were also
assayed in pore formation experiments. Significant proteolysissence and presence of the cleavage inhibitors pep-99 and acetohydroxamic acid.
methods and representative traces are shown. Pep-99 peptide (150 μM),
re independently added to calcein loaded vesicles, as controls. Release of calcein
, respectively. Maximum fluorescence intensity obtained by addition of Triton
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phenanthroline and acetohydroxamic acid. Given that 1,10-
phenanthroline interfered with calcein fluorescence emission,
acetohydroxamic acid was assayed in pore formation experi-
ments. As observed when pep-99 was used to prevent Cry3Aa
cleavage, in the presence of acetohydroxamic acid the rate of
Cry3Aa pore formation was increased, confirming the degra-
dative action of CPB membrane metalloproteases on this toxin.
Carroll et al. [5] reported that chymotrypsinized Cry3A was as
toxic as the native toxin and proposed this was due to the fact
that all Cry3A segments remained associated in solution and the
insecticidal activity was not affected by the nicking of the
polypeptide backbone. Our results also support a role for all
Cry3A constituent parts since pore-forming activity signifi-
cantly increased when proteolysis was prevented. We have
previously reported that toxin preincubation with CPB BBMV
more effectively increased Cry3A pore-forming activity than
proteolytic processing by enzymes such as trypsin and
chymotrypsin [13]. In the present study we give further
evidence to the relevance of the interaction of the toxin with
the midgut membranes to become activated. Western blot
analysis reveals that the most active toxin in terms of pore
formation (Cry3Aa BBMV preincubated in the presence of
pep-99 and acetohydroxamic acid) resembles that of the non
activated Cry3Aa protoxin in that both of them lack the
proteolytic fragments. Whether toxin interaction with the
membrane metalloprotease, independently of its catalytic
activity, may account for the activation effect observed upon
BBMV contact is still unknown, but it cannot be ruled out in
view of its dramatic impact on pore-forming activity despite
Cry3Aa proteolysis by CPB BBMV appeared to affect only a
small fraction of the protoxin.
Metalloproteases are the most diverse of the four main types
of proteases, with more than 50 families identified to date [25].
Although some of the most widely studied metalloproteases
have been digestive enzymes such as carboxypeptidases A and B
and thermolysin, a considerable advance in the understanding of
structure and function of membrane metalloendopeptidases has
been made within the last years. These proteases are implicated
not only in protein degradation but also are important in many
aspects of biology, ranging from cell proliferation, differentia-
tion and remodelling of the extracellular matrix (ECM) to
vascularization, cell migration and tumor progression. Most of
these processes require a delicate balance between the functions
of matrix metalloproteases (MMPs) or metalloprotease-disin-
tegrins (ADAMs) and natural tissue inhibitors of metal-
loproteases (TIMPs) [26]. To our knowledge only one insect
metalloprotease has been reported to process Bt toxins, a
thermolysin-like enzyme activity detected in C. quinquefascia-
tus BBMV, which was responsible for Cry11Aa cleavage [12].
In Culex, as well as it has been described in CPB with Cry3Aa
[5,6,27], it is difficult to demonstrate binding to BBMV
receptors most probably due to the rapid proteolysis of the
toxin. The relevance of the Cry11Aa proteolysis with regard to
pore formation and toxicity in C. quinquefasciatus has not been
evaluated. Whether or not the inverse relationship between
membrane proteolytic processing and pore formation that wedescribe here applies for other Bt toxins would need further
research. In the case of Cry1A toxins that do not seem to undergo
BBMV proteolytic processing [28], it has been reported that
protease inhibitors did not alter pore formation [15].
It has been proposed that aminopeptidases do not serve as
receptors for the Cry3Aa toxin [8] as it has been reported for
other Cry toxins in lepidopteran insects [29]. Remarkably, the
aminopeptidase N, as Cry1Ac receptor is independent of its
metalloprotease enzymatic activity, but the Cry1Ac region of
interaction with this receptor matched the SLDGA sequence of
Cry3Aa domain III that undergoes cleavage. In CPB, the
metalloprotease that cleaves Cry3Aa could be the counterpart of
the aminopeptidase-N identified in Lepidoptera. If this were the
case, interaction of the toxin with the metalloprotease could
render an activated form of the toxin able to trigger subsequent
steps leading to toxicity. The overall sensitivity of an insect to
Bt toxins may reflect the balance between the activation of
the toxin to an insertional-competent form and its degradative
processing by midgut insect proteases.
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